vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and John Marshall Bancorp, Inc. (JMSB). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $16.8M, roughly 1.5× John Marshall Bancorp, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs -54.6%, a 90.9% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.

CBLL vs JMSB — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.5× larger
CBLL
$24.8M
$16.8M
JMSB
Higher net margin
JMSB
JMSB
90.9% more per $
JMSB
36.3%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CBLL
CBLL
JMSB
JMSB
Revenue
$24.8M
$16.8M
Net Profit
$-13.5M
$6.1M
Gross Margin
87.3%
Operating Margin
-58.9%
Net Margin
-54.6%
36.3%
Revenue YoY
Net Profit YoY
26.8%
EPS (diluted)
$-0.35
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
JMSB
JMSB
Q1 26
$16.8M
Q4 25
$24.8M
$16.4M
Q3 25
$22.6M
$16.3M
Q2 25
$21.2M
$15.4M
Q1 25
$20.5M
$14.6M
Q4 24
$14.3M
Q3 24
$17.2M
$13.8M
Q2 24
$12.6M
Net Profit
CBLL
CBLL
JMSB
JMSB
Q1 26
$6.1M
Q4 25
$-13.5M
$5.9M
Q3 25
$-13.5M
$5.4M
Q2 25
$-13.6M
$5.1M
Q1 25
$-12.8M
$4.8M
Q4 24
$4.8M
Q3 24
$-10.4M
$4.2M
Q2 24
$3.9M
Gross Margin
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Operating Margin
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
-58.9%
47.4%
Q3 25
-64.8%
42.2%
Q2 25
-70.5%
42.7%
Q1 25
-69.3%
42.4%
Q4 24
42.5%
Q3 24
-57.8%
38.8%
Q2 24
39.7%
Net Margin
CBLL
CBLL
JMSB
JMSB
Q1 26
36.3%
Q4 25
-54.6%
36.2%
Q3 25
-59.6%
33.2%
Q2 25
-64.4%
33.1%
Q1 25
-62.4%
32.9%
Q4 24
33.3%
Q3 24
-60.6%
30.7%
Q2 24
30.9%
EPS (diluted)
CBLL
CBLL
JMSB
JMSB
Q1 26
$0.43
Q4 25
$-0.35
$0.41
Q3 25
$-0.37
$0.38
Q2 25
$-0.38
$0.36
Q1 25
$-0.36
$0.34
Q4 24
$0.33
Q3 24
$-1.85
$0.30
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
JMSB
JMSB
Cash + ST InvestmentsLiquidity on hand
$159.3M
$150.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$268.1M
Total Assets
$195.8M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
JMSB
JMSB
Q1 26
$150.2M
Q4 25
$159.3M
$130.0M
Q3 25
$168.5M
$163.6M
Q2 25
$177.4M
$116.9M
Q1 25
$182.7M
$169.1M
Q4 24
$122.5M
Q3 24
$14.1M
$177.2M
Q2 24
$182.6M
Total Debt
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
$80.9M
Q3 25
$80.9M
Q2 25
$80.8M
Q1 25
$80.8M
Q4 24
$80.8M
Q3 24
$80.8M
Q2 24
$24.7M
Stockholders' Equity
CBLL
CBLL
JMSB
JMSB
Q1 26
$268.1M
Q4 25
$155.3M
$265.6M
Q3 25
$164.1M
$259.7M
Q2 25
$172.2M
$253.7M
Q1 25
$180.9M
$253.0M
Q4 24
$246.6M
Q3 24
$-136.0M
$243.1M
Q2 24
$235.3M
Total Assets
CBLL
CBLL
JMSB
JMSB
Q1 26
$2.4B
Q4 25
$195.8M
$2.3B
Q3 25
$199.5M
$2.3B
Q2 25
$207.7M
$2.3B
Q1 25
$213.5M
$2.3B
Q4 24
$2.2B
Q3 24
$47.1M
$2.3B
Q2 24
$2.3B
Debt / Equity
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.32×
Q4 24
0.33×
Q3 24
0.33×
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
JMSB
JMSB
Operating Cash FlowLast quarter
$-10.8M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
$-10.8M
$22.6M
Q3 25
$-11.1M
$1.2M
Q2 25
$-7.5M
$7.5M
Q1 25
$-11.4M
$7.0M
Q4 24
$17.3M
Q3 24
$1.4M
Q2 24
$10.2M
Free Cash Flow
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
$-11.0M
$22.0M
Q3 25
$-11.5M
$1.2M
Q2 25
$-7.6M
$7.4M
Q1 25
$-11.6M
$6.6M
Q4 24
$16.8M
Q3 24
$1.3M
Q2 24
$10.1M
FCF Margin
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
-44.2%
134.7%
Q3 25
-50.8%
7.3%
Q2 25
-35.9%
47.8%
Q1 25
-56.4%
45.3%
Q4 24
116.9%
Q3 24
9.5%
Q2 24
80.1%
Capex Intensity
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
0.7%
3.4%
Q3 25
1.6%
0.2%
Q2 25
0.3%
1.0%
Q1 25
0.7%
2.3%
Q4 24
3.4%
Q3 24
0.8%
Q2 24
0.4%
Cash Conversion
CBLL
CBLL
JMSB
JMSB
Q1 26
Q4 25
3.82×
Q3 25
0.23×
Q2 25
1.48×
Q1 25
1.45×
Q4 24
3.61×
Q3 24
0.33×
Q2 24
2.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

JMSB
JMSB

Net Interest Income$16.5M98%
Noninterest Income$284.0K2%

Related Comparisons